Definition/General

Introduction:
-Colorectal leiomyosarcoma is a malignant smooth muscle tumor arising from the muscularis propria of the colorectum
-It represents <1% of all colorectal malignancies
-It is the second most common primary sarcoma of the colorectum after GIST
-Shows aggressive behavior with potential for metastasis.
Origin:
-Arises from smooth muscle cells of the muscularis propria
-Can originate from blood vessel walls (angioleiomyosarcoma)
-Rarely from muscularis mucosae
-Shows malignant transformation of smooth muscle cells
-Demonstrates invasive growth pattern with metastatic potential.
Classification:
-WHO classification: Malignant smooth muscle tumor
-French grading system: Grade 1-3 based on differentiation, mitoses, necrosis
-Primary vs secondary (metastatic)
-Conventional leiomyosarcoma vs epithelioid variant
-Myxoid variant also recognized.
Epidemiology:
-Peak incidence in 6th-7th decades
-Slight female predominance
-More common in rectum than colon
-Extremely rare in Indian population
-Associated with poor prognosis
-5-year survival ranges from 30-50%.

Clinical Features

Presentation:
-Abdominal mass (most common presentation)
-Rectal bleeding
-Change in bowel habits
-Abdominal pain or discomfort
-Bowel obstruction
-Weight loss
-Perforation in advanced cases.
Symptoms:
-Abdominal pain (60-70% cases)
-Rectal bleeding (40-50%)
-Constipation or diarrhea
-Palpable mass
-Constitutional symptoms (fever, weight loss)
-Anemia due to bleeding
-Tenesmus in rectal location.
Risk Factors:
-Age >50 years
-Previous radiation therapy
-Genetic syndromes (Li-Fraumeni, NF1)
-Immunosuppression
-EBV infection (in immunocompromised)
-No clear environmental factors
-Rare familial cases.
Screening:
-No specific screening guidelines
-CT scan for abdominal masses
-MRI for local staging
-Colonoscopy for mucosal lesions
-Biopsy required for diagnosis
-PET scan for staging and follow-up.

Master Leiomyosarcoma Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Large, bulky mass (usually >5 cm)
-Gray-white to tan cut surface
-Firm to hard consistency
-Irregular margins
-Areas of necrosis and hemorrhage common
-Whorled pattern may be present.
Characteristics:
-Poorly circumscribed
-Infiltrative margins
-Heterogeneous cut surface
-Necrosis in 40-60% cases
-Hemorrhage and cystic change
-Calcification occasionally present.
Size Location:
-Size typically >5 cm at presentation
-Rectum most common (50-60%)
-Cecum and ascending colon (30%)
-Sigmoid colon (15%)
-Other sites rare
-Intramural location predominant.
Multifocality:
-Usually solitary
-Multifocal disease rare
-Metastases to liver, lung, peritoneum
-Local recurrence common if incompletely excised
-Synchronous tumors rare.

Microscopic Description

Histological Features:
-Fascicles of spindle cells with malignant features
-Marked nuclear pleomorphism
-High mitotic rate (>2/10 HPF)
-Tumor necrosis common
-Infiltrative growth pattern
-Vascular invasion frequently present.
Cellular Characteristics:
-Pleomorphic spindle cells
-Enlarged hyperchromatic nuclei
-Prominent nucleoli
-Abundant eosinophilic cytoplasm
-Bizarre giant cells may be present
-Atypical mitoses.
Architectural Patterns:
-Intersecting fascicles
-Storiform pattern in some areas
-Herringbone pattern
-Loss of fascicular arrangement in high-grade areas
-Myxoid change in some cases
-Epithelioid areas occasionally.
Grading Criteria:
-French grading system: Grade 1 (well-differentiated), Grade 2 (moderately differentiated), Grade 3 (poorly differentiated)
-Based on differentiation, mitotic rate, and necrosis
-Mitoses >10/10 HPF indicates high grade
-Coagulative necrosis indicates high grade.

Immunohistochemistry

Positive Markers:
-Smooth muscle actin (SMA) positive (90-95%)
-Desmin positive (80-85%)
-Calponin positive
-h-Caldesmon positive
-Vimentin positive
-Muscle-specific actin positive.
Negative Markers:
-c-KIT (CD117) negative
-DOG1 negative
-S-100 negative
-CD34 negative (except vessels)
-Cytokeratins negative
-EMA negative.
Diagnostic Utility:
-Differentiates from GIST (c-KIT negative)
-Confirms smooth muscle origin
-Rules out other sarcomas
-SMA most reliable marker
-Desmin may be lost in high-grade tumors.
Molecular Subtypes:
-No specific molecular subtypes
-Ki-67 high proliferation index (>20%)
-p53 overexpression common
-MDM2 amplification rare
-Rb protein loss in some cases.

Molecular/Genetic

Genetic Mutations:
-Complex karyotype with multiple abnormalities
-p53 mutations common (40-50%)
-Rb pathway alterations
-PIK3CA mutations occasionally
-ATRX mutations in some cases
-Chromosomal instability.
Molecular Markers:
-High Ki-67 (>20-30%)
-p53 overexpression
-Loss of p16
-MDM2 amplification uncommon
-Cyclin D1 overexpression
-VEGF expression common.
Prognostic Significance:
-High grade indicates poor prognosis
-Size >5 cm adverse factor
-Deep location (intramural) worse prognosis
-High mitotic rate predicts recurrence
-Necrosis associated with metastasis
-Ki-67 >30% poor prognostic factor.
Therapeutic Targets:
-Complete surgical excision primary treatment
-Adjuvant chemotherapy for high-grade tumors
-Doxorubicin-based regimens
-Ifosfamide combinations
-Pazopanib for metastatic disease
-Radiation therapy for local control.

Differential Diagnosis

Similar Entities:
-Gastrointestinal stromal tumor (GIST) - c-KIT positive, different morphology
-Leiomyoma - low mitotic rate, no atypia
-Fibrosarcoma - collagenous matrix, different IHC
-Rhabdomyosarcoma - myogenin positive
-Undifferentiated sarcoma - negative smooth muscle markers.
Distinguishing Features:
-GIST: c-KIT/DOG1 positive, spindle/epithelioid cells
-Leiomyoma: <2 mitoses/10 HPF, no atypia, size <2 cm
-Fibrosarcoma: herringbone pattern, collagen-rich
-Rhabdomyosarcoma: myogenin/MyoD1 positive, cross-striations
-Undifferentiated sarcoma: lacks specific markers.
Diagnostic Challenges:
-High-grade tumors may lose muscle markers
-Small biopsy samples may not show typical features
-Dedifferentiated areas lack muscle differentiation
-Epithelioid variant mimics carcinoma
-Myxoid variant mimics myxoid sarcomas.
Rare Variants:
-Epithelioid leiomyosarcoma - epithelioid morphology
-Myxoid leiomyosarcoma - myxoid stroma
-Pleomorphic leiomyosarcoma - marked pleomorphism
-Inflammatory leiomyosarcoma - inflammatory infiltrate
-Granular cell variant - granular cytoplasm.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

Colorectal resection specimen containing a [size] cm intramural mass

Diagnosis

Colorectal Leiomyosarcoma

Classification

Malignant smooth muscle tumor, French Grade [1-3]

Histological Features

Shows fascicles of pleomorphic spindle cells with high mitotic rate ([X]/10 HPF) and tumor necrosis

Size and Extent

Size: [X] cm, extends into [muscularis propria/serosa]

Margins

Margins: [involved/uninvolved], closest margin [X] mm

Lymphovascular Invasion

Lymphovascular invasion: [present/absent]

Immunohistochemistry

SMA: positive, Desmin: positive, c-KIT: negative, Ki-67: [%]

Prognostic Factors

Grade: [1-3], Size: [X] cm, Necrosis: [present/absent], Mitoses: [X]/10 HPF

Final Diagnosis

Colorectal leiomyosarcoma, French Grade [1-3], pT[X]